Average Sales Price Formula Could Lead To Negative ASP – PhRMA
Executive Summary
The Pharmaceutical Research & Manufacturers of America is urging CMS to change the proposed methodology for including rebates in the calculation of "average sales price.
You may also be interested in...
Average Sales Price Final Rule Includes PhRMA’s Estimation Method
The methodology for estimating drug price concessions when submitting average sales prices for Medicare Part B will follow a proposal made by drug manufacturers in comments to the interim final rule
Average Sales Price Final Rule Includes PhRMA’s Estimation Method
The methodology for estimating drug price concessions when submitting average sales prices for Medicare Part B will follow a proposal made by drug manufacturers in comments to the interim final rule
Medicaid “Best Price” Should Guide Medicare ASP Calculations, CMS Says
The Centers for Medicare & Medicaid Services is advising pharmaceutical manufacturers to look at Medicaid "best price" reporting requirements for guidance when calculating "average sales price" for Medicare Part B drugs